UPDATED Apr 25, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ZAL | €24.98 | -7.7% | -32.3% | €6.5b | €32.94 | PE78x | E28.6% | n/a | ||
FIE | €42.35 | 1.0% | -9.0% | €3.6b | €54.37 | PE27.9x | E13.9% | 2.4% | ||
DOU | €20.98 | 1.5% | n/a | €2.3b | n/a | PE78.7x | n/a | n/a | ||
HBM | €51.00 | 4.9% | -3.4% | €1.6b | n/a | PE31.5x | n/a | 1.8% | ||
ZO1 | €210.00 | -2.8% | -31.1% | €1.5b | n/a | n/a | n/a | n/a | ||
RKET | €16.30 | -1.8% | -23.8% | €1.3b | n/a | n/a | n/a | 23.7% | ||
HBH | €73.60 | -0.3% | -2.7% | €1.2b | €81.82 | PE11.6x | E14.3% | 3.3% | ||
CEC | €2.13 | -2.9% | -19.9% | €1.0b | €2.27 | PB1.8x | E60.7% | n/a | ||
AG1 | €4.63 | -1.0% | -33.6% | €1.0b | €7.25 | PB1.7x | E82.9% | n/a | ||
YOU | €4.74 | 12.5% | -10.4% | €828.0m | €5.81 | PB2.7x | E78.8% | n/a | ||
MDN | €11.60 | 1.8% | -19.4% | €518.3m | n/a | PB1.3x | n/a | 5.9% | ||
H24 | €7.51 | -0.3% | 48.3% | €252.2m | €6.25 | PB1.5x | E44.2% | n/a | ||
WEW | €8.28 | 2.2% | 17.4% | €165.8m | €11.00 | PB2.2x | E98.9% | n/a | ||
FSNT | €7.58 | 5.9% | 47.5% | €150.7m | €11.83 | PB3.5x | E27.0% | n/a | ||
MRX | €2.88 | -6.8% | -25.0% | €98.1m | €6.99 | PB0.6x | E37.1% | n/a | ||
ECK | €23.00 | -0.9% | -10.9% | €85.0m | €25.00 | PE197.2x | n/a | 0.7% | ||
BIKE | €1.40 | 3.7% | -52.6% | €61.8m | €2.50 | PB0.4x | E102.4% | n/a | ||
GFG | €0.23 | -11.5% | -71.2% | €51.4m | n/a | PB0.2x | E24.2% | n/a | ||
DEX | €2.38 | 2.6% | 35.6% | €35.3m | €3.20 | PE4.4x | S0.2% | 0% | ||
ART | €5.40 | -6.1% | -37.6% | €30.4m | n/a | PE153.4x | n/a | n/a | ||
WDL1 | €4.68 | 6.4% | 22,841.2% | €26.1m | n/a | n/a | n/a | n/a | ||
WFA | €4.72 | -0.8% | -55.5% | €25.0m | n/a | PE116.1x | n/a | 3.4% | ||
G4B | €9.70 | -9.3% | n/a | €8.7m | n/a | n/a | n/a | n/a | ||
BMM | €1.45 | 0% | -12.1% | €7.0m | n/a | PE3.1x | n/a | 2.8% |